Will Investors Win With Johnson & Johnson's Planned Spinoff? Here's What History Shows
Johnson & Johnson (NYSE: JNJ) announced last week that it plans to spin off its consumer healthcare business into a separate publicly traded entity. J&J said that this move will unlock shareholder value and accelerate growth. Pfizer (NYSE: PFE) and GlaxoSmithKline established a joint venture for their consumer health units.